IMWG Conference Series - Copenhagen 2016- How does risk status affect treatment?

IMWG Conference Series - Copenhagen 2016- How does risk status affect treatment?

332 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
The doctors consider mSMART classification to look at high-, intermediate-, and standard-risk myeloma. They discuss, with the increasing depth of response in myeloma with the newer drugs, how doctors should evaluate the use of these drugs with the higher-risk disease groups. IMWG Myeloma Experts debate the latest trends in treatment June 9, 2016 Copenhagen, Denmark
Up Next Autoplay